Guidelines for the diagnosis and treatment of chronic heart failure

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial

Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911

Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia

Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165

Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions

(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725

The natural history of congestive heart failure: the Framingham study

McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448

Effect of carvedilol on survival in severe chronic heart failure

Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093

The effect of digoxin on mortality and morbidity in patients with heart failure

(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833

A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease

Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412503 · Cited by 2,489

Exercise and Physical Activity for Older Adults

Chodzko-Zajko, W. J., Proctor, D. N., Fiatarone Singh, M. A., Minson, C. T., Nigg, C. R., Salem, G. J., & Skinner, J. S. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181a0c95c · Cited by 5,153

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism

Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471

Physical Activity and Public Health in Older Adults: Recommendation from the American College of Sports Medicine and the American Heart Association

NELSON, M. E., REJESKI, W. J., BLAIR, S. N., DUNCAN, P. W., JUDGE, J. O., KING, A. C., MACERA, C. A., & CASTANEDA-SCEPPA, C. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3180616aa2 · Cited by 2,089

American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity

Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

Poole-Wilson, P. A., Swedberg, K., Cleland, J. G., Di Lenarda, A., Hanrath, P., Komajda, M., Lubsen, J., Lutiger, B., Metra, M., Remme, W. J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13800-7 · Cited by 1,872

State of the art: using natriuretic peptide levels in clinical practice

Maisel, A., Mueller, C., Adams, K., Anker, S. D., Aspromonte, N., Cleland, J. G. F., Cohen-Solal, A., Dahlstrom, U., DeMaria, A., Di Somma, S., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.07.014 · Cited by 839

The Obesity Paradox: Body Mass Index and Outcomes in Patients With Heart Failure

Curtis, J. P., Selter, J. G., Wang, Y., Rathore, S. S., Jovin, I. S., Jadbabaie, F., Kosiborod, M., Portnay, E. L., Sokol, S. I., Bader, F., et al. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.1.55 · Cited by 809

Noninvasive Home Telemonitoring for Patients With Heart Failure at High Risk of Recurrent Admission and Death

Cleland, J. G. F., Louis, A. A., Rigby, A. S., Janssens, U., & Balk, A. H. M. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.050 · Cited by 700

The prevalence of abnormal glucose regulation in patients with coronary artery disease across EuropeThe Euro Heart Survey on diabetes and the heart

BARTNIK, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.027 · Cited by 617

Expert consensus document on ?-adrenergic receptor blockersThe Task Force on Beta-Blockers of the European Society of Cardiology

(2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.002 · Cited by 557

The association between glucose abnormalities and heart failure in the population-based Reykjavik study

Thrainsdottir, I. S., Aspelund, T., Thorgeirsson, G., Gudnason, V., Hardarson, T., Malmberg, K., Sigurdsson, G., & Rydén, L. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.612 · Cited by 374

The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study

Zaphiriou, A., Robb, S., Murray-Thomas, T., Mendez, G., Fox, K., McDonagh, T., Hardman, S. M. C., Dargie, H. J., & Cowie, M. R. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.022 · Cited by 322

Anemia as a risk factor and therapeutic target in heart failure

Felker, G. M., Adams, K. F., Gattis, W. A., & O'Connor, C. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.070 · Cited by 255

Exercise based rehabilitation for heart failure

Rees, K., Taylor, R. R., Singh, S., Coats, A. J., & Ebrahim, S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003331.pub2 · Cited by 253

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial

Komajda, M., McMurray, J. J. V., Beck-Nielsen, H., Gomis, R., Hanefeld, M., Pocock, S. J., Curtis, P. S., Jones, N. P., & Home, P. D. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp604 · Cited by 234

The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening

Wang, T. J., Levy, D., Benjamin, E. J., & Vasan, R. S. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-11-200306030-00012 · Cited by 229

Orthostatic hypotension and risk of cardiovascular disease in elderly people: the Rotterdam study

Verwoert, G. C., Mattace‐Raso, F. U. S., Hofman, A., Heeringa, J., Stricker, B. H. C., Breteler, M. M. B., & Witteman, J. C. M. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01946.x · Cited by 220

Symptoms in patients with heart failure are prognostic predictors: insights from COMET

Ekman, I., Cleland, J. G. F., Swedberg, K., Charlesworth, A., Metra, M., & Poole-Wilson, P. A. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.03.007 · Cited by 200

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

Metra, M., Torp-Pedersen, C., Swedberg, K., Cleland, J. G. F., Di Lenarda, A., Komajda, M., Remme, W. J., Lutiger, B., Scherhag, A., Lukas, M. A., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi386 · Cited by 178

Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation

Pandor, A., Thokala, P., Gomersall, T., Baalbaki, H., Stevens, J., Wang, J., Wong, R., Brennan, A., & Fitzgerald, P. (2013) · Health Technol Assess · doi:10.3310/hta17320 · Cited by 159

Anaemia is an independent predictor of poor outcome in patients with chronic heart failure

Szachniewicz, J., Petruk-Kowalczyk, J., Majda, J., Kaczmarek, A., Reczuch, K., Kalra, P. R., Piepoli, M. F., Anker, S. D., Banasiak, W., & Ponikowski, P. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00574-0 · Cited by 138

Stimulating autoantibodies directed against the cardiac β1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy

Störk, S., Boivin, V., Horf, R., Hein, L., Lohse, M. J., Angermann, C. E., & Jahns, R. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.05.004 · Cited by 135

Inflammation and long-term mortality in acute congestive heart failure

Mueller, C., Laule-Kilian, K., Christ, A., Brunner–La Rocca, H. P., & Perruchoud, A. P. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.06.046 · Cited by 131

RAS inhibition in hypertension

Ibrahim, M. M. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001960 · Cited by 114

What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?

Galasko, G. I. W., Barnes, S. C., Collinson, P., Lahiri, A., & Senior, R. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi559 · Cited by 94

Type D personality and cardiac mortality in patients with chronic heart failure

Schiffer, A. A., Smith, O. R. F., Pedersen, S. S., Widdershoven, J. W., & Denollet, J. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.12.090 · Cited by 83

Activities of daily living for old persons in primary health care with chronic heart failure

Norberg, E., Boman, K., & Löfgren, B. (2008) · Scandinavian Journal of Caring Sciences · doi:10.1111/j.1471-6712.2007.00514.x · Cited by 67

Fatigue and anaemia in patients with chronic heart failure

Falk, K., Swedberg, K., Gaston-Johansson, F., & Ekman, I. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.01.016 · Cited by 59

Survival and hospitalization in heart failure patients with or without diabetes treated with β-blockers

Bobbio, M., Ferrua, S., Opasich, C., Porcu, M., Lucci, D., Scherillo, M., Tavazzi, L., & Maggioni, A. P. (2003) · Journal of Cardiac Failure · doi:10.1054/jcaf.2003.31 · Cited by 56

Fatigue and health-related quality of life in elderly patients with and without heart failure in primary healthcare

Hägglund, L., Boman, K., Olofsson, M., & Brulin, C. (2007) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2006.09.004 · Cited by 50

Use of intensified comprehensive cardiac rehabilitation to improve risk factor control in patients with type 2 diabetes mellitus or impaired glucose tolerance—the randomized DANish StUdy of impaired glucose metabolism in the settings of cardiac rehabilitation (DANSUK) study

Soja, A. M. B., Zwisler, A.-D. O., Frederiksen, M., Melchior, T., Hommel, E., Torp-Pedersen, C., & Madsen, M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.01.030 · Cited by 48

The symptom of pain with heart failure: a systematic review

Godfrey, C., Harrison, M. B., Medves, J., & Tranmer, J. E. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.01.006 · Cited by 46

Older patients with chronic heart failure within Swedish community health care: a record review of nursing assessments and interventions

Ehrenberg, A., Ehnfors, M., & Ekman, I. (2004) · Journal of Clinical Nursing · doi:10.1046/j.1365-2702.2003.00837.x · Cited by 46

Effects of education, self-care instruction and physical exercise on patients with chronic heart failure

Miche, E., Herrmann, G., Wirtz, U., Laki, H., Barth, M., & Radzewitz, A. (2003) · Zeitschrift f�r Kardiologie · doi:10.1007/s00392-003-1009-1 · Cited by 21